Stellar Biotechnologies' Shares Begin Trading on the OTCQB Marke
PORT HUENEME, CA (January 15, 2013) -- Stellar Biotechnologies, Inc. (OTCQB: SBOTF) (TSX-V: KLH), the world leader in sustainable manufacture of GMP-grade Keyhole Limpet Hemocyanin (KLH), is very pleased to announce that it was listed for trading in U.S. yesterday on the OTCQB Market under the symbol SBOTF.
OTCQB companies must be registered with and reporting to the SEC or a U.S. regulatory agency. Stellar has been fully reporting to the SEC since April 4, 2012; its regulatory filings are available on EDGAR in the U.S. as well as on SEDAR in Canada
In addition, Stellar’s stock became fully “DTC Eligible” last week, which facilitates trading of its shares electronically between brokerage firms, and market making of its shares in the U.S.